Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat with Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT03256045Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Feb 2018
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in multiple myeloma (MM), sponsored by University of Washington. Started Feb 2018; status: terminated.
02
Drugs
panobinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03256045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03256045.